Loading market data...
markets

CVS to restore coverage of Zepbound, add Eli Lilly's obesity pill to drug plans

CNBC
Read Full Article at CNBC
Share:PostShare
Ad Slot — In-Article (728x90)

CVS will add Zepbound coverage on Oct. 1, and start covering Lilly's newly approved Foundayo pill on June 1.

This is a summary. For the full story, read the original article at CNBC.

Original source: CNBC

Ad Slot — Below Article (300x250)